Toxins of Clostridium difficile

[1]  D. Lacy,et al.  The catalytic domains of Clostridium sordellii lethal toxin and related large clostridial glucosylating toxins specifically recognize the negatively charged phospholipids phosphatidylserine and phosphatidic acid , 2015, Cellular microbiology.

[2]  A. Kabakov,et al.  Role of intravenous immune globulin in streptococcal toxic shock syndrome and Clostridium difficile infection. , 2015, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[3]  R. Raffa,et al.  Clostridium difficile infection: A brief update on emerging therapies. , 2015, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[4]  S. Clare,et al.  Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections , 2015, mBio.

[5]  R. Govind,et al.  Observations on the Role of TcdE Isoforms in Clostridium difficile Toxin Secretion , 2015, Journal of bacteriology.

[6]  Jianxin Zhang,et al.  A Combination of Three Fully Human Toxin A- and Toxin B-Specific Monoclonal Antibodies Protects against Challenge with Highly Virulent Epidemic Strains of Clostridium difficile in the Hamster Model , 2015, Clinical and Vaccine Immunology.

[7]  D. Aronoff,et al.  Identification of Toxemia in Patients with Clostridium difficile Infection , 2015, PloS one.

[8]  D. Hassett,et al.  Human Clostridium difficile infection: inhibition of NHE3 and microbiota profile. , 2015, American journal of physiology. Gastrointestinal and liver physiology.

[9]  S. Norris,et al.  Toxin Synthesis by Clostridium difficile Is Regulated through Quorum Signaling , 2015, mBio.

[10]  Kevin M. D'Auria,et al.  High temporal resolution of glucosyltransferase dependent and independent effects of Clostridium difficile toxins across multiple cell types , 2015, BMC Microbiology.

[11]  W. Petri,et al.  Inflammasome Activation Contributes to Interleukin-23 Production in Response to Clostridium difficile , 2015, mBio.

[12]  J. Larabee,et al.  Exposure of Neutralizing Epitopes in the Carboxyl-terminal Domain of TcdB Is Altered by a Proximal Hypervariable Region* , 2015, The Journal of Biological Chemistry.

[13]  L. Cathala,et al.  Prevalence and pathogenicity of binary toxin–positive Clostridium difficile strains that do not produce toxins A and B , 2014, New microbes and new infections.

[14]  A. Therien,et al.  Mechanisms of Protection against Clostridium difficile Infection by the Monoclonal Antitoxin Antibodies Actoxumab and Bezlotoxumab , 2014, Infection and Immunity.

[15]  S. Tzipori,et al.  Systemically Administered IgG Anti-Toxin Antibodies Protect the Colonic Mucosa during Infection with Clostridium difficile in the Piglet Model , 2014, PloS one.

[16]  V. Young,et al.  Persistence and Toxin Production by Clostridium difficile within Human Intestinal Organoids Result in Disruption of Epithelial Paracellular Barrier Function , 2014, Infection and Immunity.

[17]  J. Rood,et al.  The role of toxin A and toxin B in the virulence of Clostridium difficile. , 2012, Trends in microbiology.

[18]  D. Decré,et al.  Prevalence and Characterization of a Binary Toxin (Actin-Specific ADP-Ribosyltransferase) from Clostridium difficile , 2004, Journal of Clinical Microbiology.

[19]  Dan He,et al.  Clostridium difficile toxin A triggers human colonocyte IL-8 release via mitochondrial oxygen radical generation. , 2002, Gastroenterology.

[20]  S. Vigna,et al.  The capsaicin VR1 receptor mediates substance P release in toxin A-induced enteritis in rats , 2001, Peptides.

[21]  R. Guerrant,et al.  Role of inducible cyclooxygenase and prostaglandins in Clostridium difficile toxin A-induced secretion and inflammation in an animal model. , 2001, The Journal of infectious diseases.

[22]  J. Sörensson,et al.  Involvement of nerves and calcium channels in the intestinal response to Clostridium difficile toxin A: an experimental study in rats in vivo , 2001, Gut.

[23]  C. Pothoulakis,et al.  Microbes and microbial toxins: paradigms for microbial-mucosal interactions II. The integrated response of the intestine to Clostridium difficile toxins. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[24]  C. Mantyh,et al.  Extrinsic surgical denervation inhibits Clostridium difficile toxin A-induced enteritis in rats , 2000, Neuroscience Letters.

[25]  J. Ballard,et al.  pH-Induced Conformational Changes inClostridium difficile Toxin B , 2000, Infection and Immunity.

[26]  C. Pothoulakis,et al.  Clostridium difficile toxin A stimulates macrophage-inflammatory protein-2 production in rat intestinal epithelial cells. , 1998, Journal of immunology.

[27]  J. Kink,et al.  Antibodies to Recombinant Clostridium difficile Toxins A and B Are an Effective Treatment and Prevent Relapse of C. difficile-Associated Disease in a Hamster Model of Infection , 1998, Infection and Immunity.

[28]  G. Corthier,et al.  Production of a complete binary toxin (actin-specific ADP-ribosyltransferase) by Clostridium difficile CD196 , 1997, Infection and immunity.